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Abstract
Background: The number of people living with advanced cancer and chronic disease has increased worldwide.
Many of these patients could benefit from palliative care, focusing on optimising the quality of life of patients and
their families facing problems resulting from life-threatening diseases. However, fragmentation and discontinuity of
palliative care services often result in suboptimal palliative care. In order to overcome these problems, models using
an integrated care approach are increasingly advocated in palliative care services. Although several models and
definitions of Integrated Palliative Care (IPC) have been developed, the effects of integrated care are still under-
investigated. Knowledge of the key components that constitute successful palliative care integration is still lacking.
This mixed methods study will examine the experiences of patients, family caregivers and professional caregivers in
order to provide insight into the mechanisms that constitute successful palliative care integration.
Methods/Design: Prospective multiple embedded case study. Three to five integrated palliative care initiatives will
be selected in Belgium, Germany, Hungary, The Netherlands and the United Kingdom. Data collection will involve
Social Network Analysis (SNA), a patient diary, semi-structured interviews, and questionnaires: Palliative care Outcome
Scale (POS), Canhelp Lite, Caregiver Reaction Assessment (CRA). Patients and family caregivers will be followed in 4
consecutive contact moments over 3 months. The diary will be kept weekly by patients. One focus group per initiative
will be conducted with professional caregivers. Interviews and focus groups will be tape recorded, transcribed and
qualitatively analysed using NVivo 10. SPSS Statistics 20 will be used for statistical analysis.
Discussion: This study will provide valuable knowledge about barriers, opportunities and good practices in palliative
care integration in the selected initiatives across countries. This knowledge can be used in the benchmark of integrated
palliative care initiatives across Europe. It will add to the scientific evidence for IPC services internationally and will
contribute to improvements in the quality of care and the quality of living and dying of severely ill patients and their
relatives in Europe.
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Background
The number of people living with advanced cancer and
chronic non-malignant disease has increased worldwide
[1]. Patients often suffer from symptoms related to their
illness and experience reduced quality of life [2,3]. Many
of these patients could benefit from palliative care, fo-
cusing on optimising the quality of life of patients and their
families facing problems resulting from life-threatening
diseases [4]. Literature has shown that palliative care has a
positive impact on the quality of life of patients with ad-
vanced cancer and advanced chronic disease at lower costs
[5,6]. However, fragmentation and discontinuity of pallia-
tive care services in Europe often result in suboptimal pal-
liative care [7]. Many patients receive palliative care in a
very late stage of their illness or not at all. This applies even
more to patients with non-malignant disease, such as
patients with Chronic Obstructive Pulmonary Disease
(COPD) and Chronic Heart Failure (CHF), compared to
patients with malignant disease [8-10]. As a result, many
patients lack adequate control or relief of symptoms to
maintain quality of life. Moreover, these patients often visit
out-of-hours services due to uncontrolled pain and other
symptoms, or experience hospital admissions during the
last phase of life [11,12]. Consequently many patients are
not able to die at their preferred place of death [3,13].
In order to overcome these problems, models using an
integrated care approach are increasingly advocated in
palliative care. These endeavours focus on the integra-
tion of palliative care either early in a certain disease tra-
jectory and/or in the organisation of care, by collaboration
and consultation with experienced (palliative) care ser-
vices and specialists [14,15]. Initiatives using an integrated
palliative care (IPC) approach have shown promising
results, reducing fragmentation and enhancing continuity
of palliative care [14]. Greer [5] and Zimmermann [16]
showed that integration of palliative care into standard
care for patients with malignant disease, could positively
affect outcomes such as quality of life, quality of care and
symptoms. Epiphaniou [17] showed that integration of
palliative care into the organisation of care, by means of
improved coordination and communication between all
primary and secondary caregivers involved in the palliative
care network of patients with lung cancer and COPD, en-
hanced continuity of care. Although several models and
definitions of IPC have been developed, the effects of inte-
grated care are still under-investigated [18,19]. Promi-
sing results are mainly based on the evaluation of
individual services, using retrospective or cross-sec-
tional data [8,20,21]. Knowledge of the key components
that constitute successful palliative care integration is
still lacking [22,23].
In order to address this knowledge gap, the EU-funded
(FP7) collaborative research project “Patient-centred in-
tegrated palliative care pathways in advanced cancer
and chronic disease” (InSup-C) was planned. The aim of
the overarching study is to identify best or promising
practices in IPC across Europe. A central component of
the project is a prospective mixed methods cohort study
that will be carried out with patients and their caregivers
receiving palliative care. This mixed methods study will
examine the experiences of patients, family caregivers
and professional caregivers with palliative care provision
and will provide insight into the mechanisms that con-
stitute successful palliative care integration. We expect
that this knowledge will contribute to the improvement
and implementation of IPC across Europe.
The research question addressed in this study is:
How do patients with advanced cancer, COPD and
CHF, their family and professional caregivers experience
care provision in a range of IPC initiatives in five
European countries?
This question will be explored by an examination of what
care is provided by whom and to what extend caregivers
work together to provide patient-centred, continuous care.
Important aspects of this exploration also entail whether
the needs, problems and expectations of patients and fa-
mily caregivers are met, and how relationships between
patients/family caregivers and professional caregivers are
experienced. As family caregivers are often closely involved
in palliative care provision, their perspectives on caring for
the patient will also be explored. Subsidiary questions
emerging from the research question are:
1. How is the care network of the patient organised
with respect to the type, properties and quality of
relationships between patients and family/
professional caregivers?
2. What opinions do patients and family and
professional caregivers have on the continuity and
quality of care provided?
3. How do patients rate their symptoms and quality of
life?
4. How do family caregivers rate their burden or
reward of care giving?
The objective of this paper is to present the protocol of
this patient and caregivers study, including a detailed de-
scription of the study design and the methodological ap-
proach. The methodology described in this paper will also
serve as a reference for future publications about the study.
Methods/Design
Study design
This study uses a prospective multiple embedded case
study design [24]. This design enables us to examine the
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quality of care of a range of IPC initiatives in-depth and
over time, as it is experienced in daily care giving prac-
tice. This design also allows us to explore the embedded
subunits of multiple cases in order to understand more
about the case itself. In this study the cases are IPC ini-
tiatives (see Figure 1). The embedded subunits are pa-
tients, family caregivers and professional caregivers and
their experiences with care provision in the initiatives.
Detailed analysis of these embedded subunits includes:
the organisation of the patient’s care network and re-
lationships with and collaboration between professional
caregivers in this network, perceived quality of care,
quality of life and symptoms of patients, perceived bur-
den and reward of care giving of family caregivers. The
multiple case study design also allows for comparison
between IPC initiatives, each one with its own organisa-
tion and set-up (roles, responsibilities, relationships). In
order to enable comparison the data collection methods
for patients, family caregivers and professional caregivers
will be the same for all IPC initiatives.
Selection of IPC initiatives (cases)
The study will be conducted in five European countries;
Belgium (Flanders region), Germany, Hungary, The
Netherlands and the United Kingdom. In each country,
three (Belgium) or five (the other countries) IPC initia-
tives will be recruited to the study. It is a novelty that in
palliative care research patients and (family) caregivers’
views will be investigated at this large European scale.
As integrated palliative care is an upcoming and under-
investigated field, there is no theoretical framework or
prevailing standard on which we can base the number
and selection of cases (IPC initiatives). We expect that
three-five initiatives per country and 23 in total will be
enough to generate insight in how current IPC initiatives
vary in service provision (e.g. diagnostic group(s), organ-
isational structure, caregivers and settings that are in-
volved, etc.) and what this means for patients’ and
caregivers’ perspectives on the (quality of) service provision
and its barriers and benefits. Although this number may
not be enough to reach full saturation, we need to take into
account the reality of inclusion of a rather vulnerable pa-
tient group which will demand large efforts in time and re-
sources in the project team.
As there was no unanimously agreed definition of IPC
beforehand, the project team formulated a working def-
inition. This was based on the literature [25-29] and on
discussions in several project team meetings. The final
definition is as follows: “Integrated palliative care in-
volves bringing together administrative, organisational,
clinical and service aspects in order to realise continuity
of care between all actors involved in the care network of
patients receiving palliative care. It aims to achieve qual-
ity of life and a well-supported dying process for the
patient and the family in collaboration with all the care-
givers, paid and unpaid”. Using this definition and the
criteria below, which derived from the definition, local
initiatives in the five countries will be identified, exam-
ined, and selected for inclusion. Experts in palliative and
integrated care across the participating nations will be
consulted in the identification process.
Selection criteria for IPC initiatives
1. the initiative is an established local palliative care
collaboration;
2. the collaboration must contain at least two different
organisations;
3. a hospital can be part of that collaboration;
4. collaborating healthcare professionals must provide
direct patient care (not only an advisory function);
5. the collaboration has a multidisciplinary background
(professionals of different professions must be
involved, e.g. physician (specialist, GP), nurse
(specialist), social worker, Allied Health Professional,
spiritual worker, complementary therapist, others);
Figure 1 Multiple embedded case study design of our study about the experiences of patients, family and professional caregivers with
IPC in Europe.
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6. the collaboration aims to provide palliative care for
one or more target diagnostic groups in the study
(COPD/CHF/Advanced cancer).
Participants (embedded subunits)
Patients with advanced cancer, COPD or CHF, their family
caregivers and professional caregivers will be recruited
from each IPC initiative taking part in the study. Signed
informed consent forms will be obtained before study
entry.
Patients and family caregivers
Patients (and if present one family caregiver per patient)
will be recruited by their attending doctor or other pro-
fessional involved in their care. A family caregiver, de-
fined as the person who non-professionally takes care
and supports the patient for most of the time, will be
identified by the patient. Family caregivers may not ne-
cessarily be a family member [30]. Participants need to
meet the inclusion criteria (see “Inclusion criteria for pa-
tients and family caregivers”) in order to be eligible to
take part in the study. In order to gain variation in pa-
tients’ experiences with care provision at different time
points in their disease trajectories, we strive to purpo-
sively recruit patients who are at different time points in
their disease trajectories.
Inclusion criteria for patients and family caregivers
Patients & family caregivers
1. 18 years or above
2. Able to communicate in the national language
(Dutch, English, German, Hungarian)
3. Cognitively able to complete questionnaires and to
participate in interviews.
Patients
1. The patient’s attending doctor answers “No” to the
surprise question: “Would you be surprised if the
patient died within 1 year?”
2. Any of the following diagnoses:
A) Advanced cancer (cancer with local progression
and/or distant metastasis at presentation)
B) Severe heart failure in accordance with NYHA
classification stage III-IV
C) COPD Gold stage IV classification
We aim to achieve a total sample of 138 included pa-
tients and 138 family caregivers. This means an inclusion
of six patients and six family caregivers per IPC initiative.
We expect that this small number is attainable within
18 months, as this will be done in a multicenter study
across 5 European countries with dedicated researchers
per site. Herewith, we have also taken into account that
the qualitative data analysis is not postponed to the end of
data collection, but will already start after the first inter-
views, as data analysis in qualitative research is an iterative
process until the end of the data collection period. In the
recruitment of patients and family caregivers we will take
account of a 30% attrition rate [31].
Professional caregivers
Professional caregivers who are involved in the patient’s
care network (identified by the patient) and who are in-
volved in the selected IPC initiatives will be invited for
participation in a focus group. We aim to conduct 23
focus groups each with 6-10 participants. In order to
maximize an exploration of different perspectives on the
initiative as it is experienced in practice, we aim at a
convenience sample containing various professional roles
and responsibilities within the initiative. The final invita-
tion list will be made after inclusion of the last patient,
with alternatives in case of decline.
Data collection
There will be four consecutive contact moments with
patients and family caregivers with an interval of one
month (baseline, month 1, month 2, month 3). These
are displayed in Table 1. At baseline and at month 3
there will be a face-to-face contact with the patient and
his/her family caregiver. During these contacts we will
conduct semi-structured interviews and assess the care-
giver network analysis with the patient. At baseline,
month 1, month 2 and month 3 the patient and family
caregiver will complete the questionnaires. Weekly, be-
tween baseline and month 3, the patient will keep a
diary. The questionnaires and diary will be completed by
the patient and/or family caregiver themselves or with
the help of a researcher, by telephone.
If a patient dies during the study period, we will con-
tact the family caregiver to offer our condolences and,
dependent on the circumstances of the bereaved carer,
will ascertain if they wish to have a final semi-structured
interview. If so, we will contact them again to make an
arrangement for the final interview at a time of their
convenience between 4 and 12 weeks afterwards. We will
not administer any questionnaires anymore. Per initiative
there will be one focus group with professional caregivers
at the end of the data collection.
The expected duration of the entire study period will be
18 months, including recruitment, data collection, and
analysis. Data collection is scheduled to start in June 2014
and to finish at the end of 2015. The data collection
methods that will be applied to assess the outcome param-
eters are described in Table 1.
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Patients
Social Network Analysis
The organisation of the care network of patients, including
the type, properties and quality of relationships between
patients, family caregivers and professional caregivers will
be examined using a social network approach. Social net-
work analysis (SNA) is a method to investigate patterns of
relations, communication and collaboration between actors
in a given network. In health care research SNA has been
applied to investigate organisational structures, processes,
and service provision. The results can be used to design or
implement interventions to change health care policy or
practice [32-34]. To analyse the organisation of the pa-
tient’s care network a structured questionnaire, based on
previously published questionnaires [35,36], was devel-
oped by the project team. The final questionnaire (see
Additional file 1) contains 13 questions and examines
contacts between patient and caregivers in his/her care
network, evaluation of services provided, perceived con-
tinuity of care, and collaboration between caregivers in
the network. The patient’s care network, including the
type, properties and quality of relationships will be further
explored using a patient diary and semi-structured inter-
views (discussed below).
Patient diary
A patient diary will be used to collect data about the per-
ceived quality of care during the palliative care trajectory
and the nature of professional caregiver contact. The diary
will be kept weekly and contains two questions:
1. Did you have contact with a non-family caregiver
during the last week? (e.g. palliative care team con-
sult, home care, GP, psychologist, hospital, other)
2. If yes, how would you rate the care you received?
The answer to the second question is given on a 5-
point (Likert) scale, rating from 1 (poor) to 5 (excellent).
Information provided in the diary will be explored in the
last semi-structured interview. If the patient is unable to
fill in the diary on his/her own the family caregiver/re-
searcher may assist the patient.
Recording contacts between patients and their care-
givers will provide evidence about care utilisation and per-
ceived quality. Information gleaned from the patient diary
and the SNA will enable an in-depth examination of the
development and changes in the patient’s care network
over time. Combining data from both tools – together
with that from the semi-structured interviews (discussed
below) – will also allow a detailed explication of the extent
of palliative care integration in the participating initiatives.
Patients and family caregivers
Semi-structured interview
Semi-structured interviews will be used to explore views
of patients and family caregivers about their experiences
Table 1 Data collection schedule
Outcome parameter Data collection
method
Baseline Week
1-4
Month
1
Week
5-8
Month
2
Week
9-12
Month
3
End of data
collection
Patient
Organisation of patient’s
care network, Collaboration
between professional caregivers
Caregiver network analysis
questionnaire
X X
Experiences with IPC initiative,
Quality of Care
Semi-structured interview X X
Diary X X X
Quality of Life, Perceived
symptoms
Palliative care Outcome
Scale
X X X X
Satisfaction with Care Canhelp Lite X X X X
Family caregiver
Experiences with IPC initiative,
Quality of Care
Semi-structured interview X X
Quality of Life, Perceived
symptoms of patient
Palliative care Outcome
Scale
X X X X
Satisfaction with Care Canhelp Lite X X X X
Burden & Reward of care giving Caregiver Reaction
Assessment
X X X X
Professional caregiver
Experiences with IPC initiative,
Quality of Care, Collaboration
between professional caregivers
Focus group X
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with the IPC services they receive. These will be con-
ducted by trained researchers from the project teams in
each of the five participating countries. In principle the
interviews will be conducted separately. For practical
reasons the researcher may deviate from this and con-
duct the interview with both patient and family caregiver
at the same time. In order to minimize influences be-
tween patients and family caregivers when they are to-
gether, we will emphasize before the start of the
interview that we are interested in both the personal
view of the patient and the family caregiver. Further we
will ask either the patient or family caregiver directly for
his/her own view, e.g.: “Is this problem you just men-
tioned also a problem in your own view, or is this a
problem in the view of [name of family caregiver]?”. Pa-
tients in this study are vulnerable and often more com-
fortable in the surrounding of their partner, so we do
not want to be too strict in a separate interview to re-
strict the burden for the patient as much as possible.
Topics of the interviews include:
1. Exploration of problems and needs of the patient
2. Exploration of the contacts and relationships of
patients and family caregivers with professional
caregivers
3. Exploration of satisfaction and perceived deficits in
service provision from the perspective of patients
and family caregivers
4. Exploration of the views of patients and family
caregivers on the collaboration between professional
caregivers in the care network of the patient. A
second interview at month 3 will enable an
exploration of the care experience over time.
5. The final interview will include a review on the most
important problems and needs in the dying phase
from the perspective of the bereaved family
caregiver, which caregivers were involved in this
phase and just after bereavement, and how the care
provision was experienced by the bereaved family
caregiver.
Questionnaires
Demographic and other relevant data that describe the
population contributing to this study will be collected at
baseline using the questionnaires presented in Table 1.
With regard to the vulnerable population of seriously ill
patients and the international nature of the study, ques-
tionnaires were selected based on: validation and/or ap-
plicability in palliative care populations of patients with
cancer and chronic disease, time needed for completion
in order to limit burden of assessment, and available
translations into the national languages of the countries
involved in the study (Dutch, English, German, Hungarian).
Questionnaires that had not yet been translated were trans-
lated using a forward-backward translation procedure [37].
Palliative care Outcome Scale (POS)
The Palliative care Outcome Scale – version 1 will be used
with patients and family caregivers to measure quality of
life and perceived symptoms of patients. It is widely used
and tested and is validated for use in palliative care. The
completion time is short, approximately 7 minutes [38].
The POS has been translated into Chinese, English,
Dutch, German, Italian, Portuguese, Punjabi, Spanish and
Urdu. There is a patient and a caregiver version.
Canhelp Lite
The Canhelp Lite will be used with patients and family
caregivers to measure satisfaction of care. It was devel-
oped in Canada, validated for use in palliative care and
applied to patients with advanced, life-limiting illnesses.
It is applicable in both institutional and community
based settings. There is a Patient Questionnaire, Care-
giver Questionnaire and a Bereavement Questionnaire
[39]. Only the Patient Questionnaire and Caregiver
Questionnaire will be used in this study. The Canhelp
Lite has a completion time of approximately 10 minutes
for both the patient and caregiver version and has been
translated into English and French.
Family caregivers
Caregiver Reaction Assessment (CRA)
The Caregiver Reaction Assessment will be used with
family caregivers to measure their perceived burden and
reward of care giving. It measures both positive and
negative reactions to care giving [40]. The CRA is widely
used and extensively tested and has a completion time
of approximately 10 minutes. It has been translated into
Dutch, English, German, Japanese, Norwegian and Thai.
The CRA has been applied to family caregivers as well
as significant others for patients with physical, chronic
and mental impairments and malignant diseases [41].
Professional caregivers
Focus group
Focus groups will be used to obtain insight into the ex-
periences of professional caregivers with providing IPC.
The interviews will address professional caregivers’ views
concerning the quality of IPC in their initiative and is-
sues involved in working across organisational boun-
daries to provide that care. One focus group will be
conducted in each of the participating services. Topics
that will be discussed include: components considered
important for high quality integrated care, set-up of the
initiative (roles, responsibilities, relationships), expecta-
tions and/or future improvements.
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Data management and analysis
Anonymous participant data will be stored in a pro-
tected database Castor EDC (Electronic Data Collection)
with a login function. The master database will be kept
at the centre of the research coordinator Radboud Uni-
versity Medical Centre in the Netherlands.
Interviews will be tape recorded and transcribed
verbatim. Transcriptions will be analysed using content
analysis techniques supported by the qualitative analysis
software package NVivo 10. Researchers from each part-
ner country will jointly develop a preliminary coding
schedule with the results of the first two interviews. This
code book will be used for the baseline and final inter-
views. The codes and themes will form the basis of the
coding strategy throughout data collection and the data
analysis. Analysis will be iterative during the fieldwork
phase in order to allow emergent themes to be incorpo-
rated into the data collection. This procedure will also
be used to analyse the focus group data. For the focus
groups a separate code book will be developed by the
researchers.
In general, the analysis will focus on the similarities
and differences between the IPC initiatives (e.g. the diag-
nostic group(s), organisational structure, the caregivers
and settings that are involved in the care provision) and
what these mean for the views of patients, family care-
givers and professional caregivers on the care provision.
The analysis will result in five country specific reports
about the experience of using and providing IPC in the
last year of life. IPC country specific reports will be ana-
lysed and summarised in one overarching document.
This report will provide a trans-national perspective on
the lived experience of IPC services from the particular
standpoints of the service users and professional care-
givers involved.
Statistical analysis will be performed using SPSS Statis-
tics 20 on the quantitative data derived from the ques-
tionnaires. We will use descriptive statistics such as
frequencies, crosstabs, means, standard deviation in the
data analysis in order to describe the characteristics of
the participant population. During this analytical phase
we will integrate the quantitative variables and qualita-
tive findings so as to draw a more complete picture of
IPC across Europe.
Training sessions
In order to assure high quality and uniformity of data
collection and analysis in all five countries two training
sessions will be organised. These sessions will support
researchers in preparing and conducting interviews,
performing reliable and valid qualitative research and
processing data. Training will also focus on preparing
researchers to conduct research with potentially vulner-
able participants.
Ethical issues
As in all ethically conducted research, informed consent
will be obtained to guarantee voluntary participation and
participants may withdraw at any time should they wish
to. For these reasons we believe that the potential for
risk in this study is minimal and that it may even benefit
participating patients and family caregivers [42,43].
In order to test this expectation we added four ques-
tions about how patients experienced participation in
the interview study (“thoughts on the studies”) and po-
tential distress or satisfaction related to the study partici-
pation. These questions will be asked after the first and
final patient interview. The questions were derived from
Gysels [42] who conducted a qualitative study with 76
palliative care patients from the UK. This study concluded
that although patients experienced thinking about the
future as difficult, sharing problems was therapeutic
and being able to contribute to research was considered
empowering [42]. Using the same questions in our study
enables us to contribute to this ethical debate.
In order to minimize the burden of data collection on
patients and family caregivers, questionnaires and diaries
have a short completion time and the total duration of
interviews will be limited to a maximum of 60 minutes.
Interviews will be conducted by researchers who are ex-
perienced and well trained in research with vulnerable
patients.
For professional caregivers, participating in the study
may be beneficial because during the interviews they will
have the opportunity to reflect on their experiences of
the provision of palliative care and their collaboration
with other professional caregivers involved in the IPC
initiative under examination. This reflection could be a
prompt to improve their collaboration with other care-
givers and may provide an impetus to improve daily
practice in their local collaborations.
Ethical approval has been granted by the ethical review
committees of Hungary, The United Kingdom and
Germany. The study does not fall within the remit of the
Dutch Act on Human Research and for this reason did not
have to go through the Dutch ethical review committee. In
Belgium the ethical review procedure is in a final stage.
Discussion
Strengths
The prospective multiple embedded case study design al-
lows for exploration of IPC trajectories as experienced by
patients and family caregivers. This includes palliative care
service utilisation, perceived quality of life, quality of care,
symptoms and perspectives on the collaboration between
caregivers in the patient’s care network. The prospective
design allows the possibility to examine these palliative
care trajectories more in-depth. It also enables the explo-
ration of IPC services utilisation and the collaboration
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between caregivers within the patient’s care network
throughout the palliative care trajectory over time.
The international perspective of this study has the ad-
vantage that we can compare experiences of service users
and providers in a range of different health care contexts
in Europe. We expect that this will provide valuable infor-
mation about barriers, opportunities and good practices in
palliative care integration in the selected initiatives across
countries. This information can be used in the bench-
marking of initiatives in Europe and the further imple-
mentation of integrated care.
Challenges
One challenge of a patient study on an international scale
is that it needs to meet ethical requirements in several
countries. Our study shows that it is feasible to develop
such an international multicenter palliative care patient
study protocol which meets the nuanced requirements of
different national ethical and research governance pro-
cesses, whilst applying the same data collection and scien-
tific analysis procedures across national boundaries.
We realise that three months is a rather arbitrary period
to follow patients who may have a much longer or shorter
palliative care trajectory. Identifying those who are in the
last year of life, yet functioning well enough to engage
with and complete the study over a three month period
can be problematic. This challenges us to collect as
complete information as possible about experiences of pa-
tients throughout their entire palliative care trajectory and
to warrant accurate inclusion of patients.
Conclusion
This study will provide valuable data about patients’,
family and professional caregivers’ experiences with vari-
ous IPC initiatives, including quality of care, quality of
life, symptoms, burden and reward of care giving, rela-
tionships with and collaboration between professional
caregivers. These data will provide important insights
into what constitutes best practice, as perceived by those
using and providing IPC services, across a range of dif-
ferent health economies in Europe. This knowledge will
add to the scientific evidence for IPC services inter-
nationally and will contribute to improvements in the
quality of care and the quality of living and dying of se-
verely ill patients and their relatives in Europe.
Additional file
Additional file 1: Caregiver network analysis questionnaire. Presents
the questions used in the caregiver network analysis questionnaire.
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